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Sphingosine 1- phosphate is a bioactive 
sphingolipid that regulates cell growth 
and suppresses programmed cell death. 
The bio- synthesis of sphingosine 1- 
phosphate is catalyzed by sphingosine 
kinase (SK) but the mechanism by which 
the subcellular localization and activity of 
SK is regulated in response to various 
stimuli is not fully understood. To 
elucidate the origin and structural 
determinant of the specific subcellular 
localization of SK, we performed 
biophysical and cell studies of human 
SK1 (hSK1) and selected mutants.  
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In vitro measurements showed that hSK1 
selectively bound phosphatidylserine over 
other anionic phospholipids and strongly 
preferred the plasma membrane- 
mimicking membrane to other cellular 
membrane mimetics. Mutational analysis 
indicates that conserved Thr
54 
and Asn
89
 
in the putative membrane- binding 
surface are essential for lipid selectivity 
and membrane targeting both in vitro and 
in the cell. Also, phosphorylation of Ser
225
 
enhances the membrane affinity and 
plasma membrane selectivity of hSK1, 
presumably by modulating the 
interaction of Thr
54
 and Asn
89 
with the 
membrane. Collectively, these studies 
suggest that the specific plasma 
membrane localization and the activation 
of SK1 is mediated largely by specific 
lipid- protein interactions.  
 
Sphingosine 1- phosphate (S1P)
3
 is a 
recently identified bioactive lipid that can 
act both extracellularly and intracellularly as 
a first and a second messenger, respectively 
(1). It has been shown that S1P is excreted 
into serum from platelets and binds 
members of the endothelial differentiation 
gene receptor family (S1P1-5) to activate 
cellular processes such as differentiation, 
migration, and mitogenesis (2). 
Intracellularly, S1P has been implicated in 
signaling cascades that lead to cytoskeletal 
changes, motility, release of intracellular 
Ca
2+ 
stores, and protection from apoptosis 
(3-6). S1P is formed from sphingosine 
(SPH) by sphingosine kinase (SK) and is 
degraded by S1P lyase and S1P 
phosphatases (1). In the resting state of cells, 
the balance between S1P formation and 
degradation maintains the low basal levels 
of S1P. However, cellular S1P levels have 
been shown to increase rapidly and 
transiently by agonists that activate SK, such 
as tumor necrosis factor- α (7, 8), platelet- 
derived growth factor (9), nerve growth 
factor (10, 11), muscarinic acetylcholine 
agonists (12), or phorbol esters (13, 14).  
 Two types of mammalian SKs (SK1 
and SK2) have been characterized so far (15, 
16), both of which are primarily cytosolic 
proteins. A recent study suggested that a 
phorbol ester, phorbol 12- myristate 13- 
acetate (PMA), induces the protein kinase C 
(PKC)- mediated phosphorylation and the 
localization of SK1 to the plasma membrane 
in human embryonic kidney (HEK) 293 
cells (17), which leads to enhanced release 
of S1P to the media. Subsequently, it was 
reported that PMA and tumor necrosis 
factor- α induced the phosphorylation of 
Ser
225
 of SK1 through the activation of 
mitogen- activated protein kinase, 
extracellular signal- regulated kinase ½, 
which resulted in plasma membrane 
localization and activation of SK1 (18). It 
has been also reported that the subcellular 
localization of SK1 is medicated by 
interactions with putative adapter proteins 
(19, 20). However, it is still unknown how 
SK is specifically targeted to the plasma 
membrane and how phosphorylation triggers 
the subcellular localization of SK. To 
elucidate the origin and structural 
determinants of its specific subcellular 
localization of SK, we performed 
biophysical and cell studies of human SK1 
(hSK1) and selected mutants. The results 
from this study provide new insight into 
how the membrane recruitment of this 
important protein is regulated in the cell.  
 
EXPERIMENTAL PROCEDURES 
Materials- 1-Palmitoyl- 2- oleoyl- 
sn- glycerol- 3- phosphatidic acid (POPA), 
1- palmitoyl- 2- oleoyl- sn- glycerol- 3- 
phosphocholine (POPC), 1- palmitoyl- 2- 
oleoyl- sn- glycero- 3- phosphoethanolamine 
(POPE), 1- palmitoyl- 2- oleoyl- sn- 
glycero- 3- phosphoglycerol (POPG),  1- 
palmitoyl- 2- oleoyl- sn- glycero- 3- 
phosphoinositol (POPI), 1- palmitoyl- 2- 
oleoyl- sn- glycero- 3- phosphoserine 
(POPS), and D-erythro-SPH (C20)were 
purchased from Avanti Polar Lipids, Inc. 
(Alabaster, AL) and used without further 
purification. PMA was from Sigma. Silica 
thin layer chromatography G-60 plate was 
from Merck. 
Protein Expression and Purification- 
All SK1 proteins were expressed in 
baculovirus- infected Tn5 cells as soluble 
proteins with a C- terminal His6 tag and 
purified from the cell extracts using a Ni
2+
- 
nitrilotriacetic acid- agarose column 
(Qiagen) according to the manufacturer’s 
protocol. All proteins were >90% pure 
electrophoretically. Protein concentration 
was determined by bicinchoninic acid 
method (Pierce).  
Surface Plasmon Resonance 
Analysis- The kinetic SPR measurements 
 ere performed at     C in 20 mм HEPES, 
pH 7.4, containing 0.16 M KCl using a 
lipid- coated L1 chip in the BIACORE X 
system as described previously (21). Cell 
membrane- mimicking vesicles were 
prepared as described (22). The control 
sensor surface was coated with 100% POPC 
vesicles for which all hSK1 proteins have 
extremely low affinity, and the active sensor 
surface was coated with vesicles indicated in 
TABLES ONE and TWO. All data were 
analyzed using BIAevaluation 3.0 software 
(Biacore) to determine ka and kd, and 
equilibrium dissociation constant (Kd) was 
then calculated using an equation, Kd= kd/ka 
assuming 1:1 binding: i.e. protein + (protein 
binding site on vesicle)  
(complex) (21).  
 Monolayer Measurements- Surface 
pressure (π) of solution in a circular Teflon 
trough (4 cm diameter x 1 cm deep) was 
measured using a Wilhelmy plate attached to 
a computer- controlled Cahn electrobalance 
as described previously (23). Five to ten μl 
of phospholipid solution in ethanol/ hexane 
(1:9 (v/v)) was spread onto 10 ml of 
subphase (20 mм HEPES, pH 7.4, 
containing 0.16 M KCL, and either 0.1 mм 
EGTA or 0.1 mм CaCl2) to form a 
monolayer with a given initial surface 
pressure (πo). Once the surface pressure 
reading of monolayer had been stabilized 
(after about 5 min), the protein solution 
(typically 40 μl)  as  injected into the 
subphase through a small hole drilled at an 
angle through the wall of the trough and the 
change in surface pressure (Δπ)  as 
measured as a function of time. Typically, 
the Δπ value reached a maximum after  0 
min. The maximal Δπ value at a given π 
depended on the protein concentration and 
reached a saturation value (i.e. [hSK1] ≥ 1.0 
μg/ ml). Protein concentrations in the 
subphase were therefore maintained above 
such values to ensure that the observed Δπ 
represented a maximal value. The critical 
surface pressure (πc) was determined by 
extrapolating the Δπ versus πo plot to the x- 
axis (24).  
 SK1 Activity Assay- In vitro hSK1 
activity was measured in the absence or 
presence of lipid vesicles according to the 
procedure by Olivera and Spiegel (25). For 
the assays without lipid vesicles, the 
recombinant hSK1 was added to 20 mм Tris 
buffer (pH 7.4) containing 0.16 м KCl, 5 μм 
ᴅ- erythro- SPH- bovine serum albumin 
adduct (99.7:0.  in mole ratio), 1 mм [γ- 
32
P]ATP (Amersham Biosciences; 1 μCi), 
and 500 μм MgCl2. After the reaction 
mixture  as incu ated at     C for  0 min, 
lipids were extracted with 2.5 volumes of 
chloroform/ butanol/ HCl (50:50:1, v/v/v/), 
and the organic layer was dried under a 
gentle stream of nitrogen. SPH and S1P 
were separated by thin layer 
chromatography using butanol/ methanol/ 
acetic acid/ water (80:20:12:20, v/v/v/v) as 
eluent. Bands corresponding to S1P were 
scraped and the radioactivity measured 
using a scintillation counter. Activity assays 
in the presence of lipid vesicles were 
performed in  0 mм Tris  uffer (pH 7.4) 
containing 0.16 м KCl, 5 μм ᴅ- erythro- 
SPH incorporated into phospholipid vesicles 
of various compositions (5 μм total 
concentration), 1 mм [γ- 32P]ATP 
(Amersham Biosciences; 1 μCi), and 500 μм 
MgCl2. For cellular SK1 activity assays, 
transfected HEK293 cells were treated with 
  μм PMA for the indicated times, and 10 
min before the end of the time point, cells 
 ere pulsed  ith  00 nм ᴅ- [erythro- 
3
H]SPH (American Radiolabeled Co.; 1.0 
μCi). The secreted S1P  as extracted and 
counted as described above.  
 Cell Culture, Transfection and 
Confocal Microscopy- Wild type hSK1 and 
its mutants were su cloned in- frame  ith a 
C- terminal enhanced green fluorescent 
protein (   P) into the p    vector. Sta le 
H K 9  cells expressing ecdysone receptor 
( nvitrogen)  ere gro n in  ul ecco’s 
modified  agle’s medium containing 10  
fetal  ovine serum at  7  C with 5% CO2 and 
98% humidity. The cell transfection and the 
protein expression were performed as 
described elsewhere (22). Confocal 
imagining was performed using a four 
channel Zeiss LSM 510 laser scanning 
microscope. EGFP was excited using the 
488- nm line of an argon/ krypton laser. A 
505- nm line pass filter and a x 63, 1.2 
numerical aperture waster immersion 
objective were used for all experiments. 
Immediately before imagining, induction 
media was removed as the cells were 
 ashed t ice  ith 1 mм H P S (pH 7.4), 
containing  .5 mм MgCl2, 140 mм  aCl, 5 
mм KCL, and 6 mм sucrose. The cells  ere 
then overlaid with the same buffer and 
imaged. Translocation experiemtns were 
monitored by scanning every 30 s following 
treatment of the cells with 2 μм PMA. The 
time lapse changes in EGFP intensity ratio 
at the plasma membrane (= plasma 
membrane/ [plasma membrane + 
cytoplasm]) were determined as described 
previously (22). 
 Determination of 
Ser
225
Phosphorylation by Mass 
Spectrometry- The hSK1 bands were 
excised from the Coomassie Brilliant Blue- 
stained sodium dodecyl sulfate- 
polyacrylamide gel. The excised bands were 
washed three times with acetonitrile/ H2O 
(1:1, v/v) for 10 min and dehydrated with 
acetonitrile. Then, the bands were finally 
washed with 1:1 (v/v) solution of 
acetonitrile and 100 mм ammonium 
bicarbonate and dried under vacuum. 
Proteins contained in gel pieces were 
reduced  y using 10 mм Tris ( - 
car oxyethyl) phosphine hydrochloride in 
0.1 м ammonium  icar onate at 56  C for 45 
min and then alkylated  ith 55 mм 
iodoacetamide in 0.1 м ammonium 
bicarbonate at room temperature for 30 min. 
the alkylated sample was washed as 
described above, dried, and soaked in 
sequencing- grade trypsin (500 ng) on ice 
for 45 min. Then, the gel pieces were 
immersed in 100 μl of 500 mм ammonium 
 icar onate at  7  C for 14- 18 h. Resulting 
peptides were extracted sequentially for 20 
min  ith 45  acetonitrile in  0 mм 
ammonium bicarbonate, 45% acetonitrile in 
0.5% trifluoroacetic acid, and 75% 
acetonitrile in 0.25% trifluoroacetic acid 
with agitation. Pooled peptide extracts were 
evaporated under vacuum. Digested peptides 
were dissolved in Solvent A (5% acetonitrile 
and 0.1% formic acid in H2O) and loaded 
onto fused silica capillary columns 
containing 8 cm of 5- μm particle size Aqua 
C18 reverse- phase column material. The 
column was placed in- line with an Agilent 
HP 1100 quaternary LC pump and a splitter 
system was used to achieve a flow rate of 
250 nl/ min, with a 90- min gradient of 
Solvent A and Solvent B (80% acetonitrile 
and 0.1% formic acid in H2O). Eluted 
peptides were directly electrosprayed into an 
LCQ Deca XP Plus mass spectrometer 
(ThermoFinnigan, Palo Alto, CA) by 
applying 2.3 kV of DC voltage. A data- 
dependent scan consisting of one full mass 
scan (400- 1400 m/z) and three data- 
dependent tandem mass scans were used to 
generate tandem mass spectra of eluted 
peptides. Normalized collision energy of 
35% was used throughout the data 
acquisition. Tandem mass spectra were 
searched against an in- house protein data 
base using TurboSequest and 
phosphorylation modification (+ 80 on Ser, 
Thr, and Tyr) was considered in the 
differential modification search. Bioworks 
version 3.1 was used to filter the search 
results and the following Xcorr values were 
applied to different charge states of peptides: 
1.8 for singly charged peptides, 2.2 for 
doubly charged peptides, and 3.2 for triply 
charged peptides. Tandem  mass spectra for 
phosphorylated peptides were generated 
using Xcalibur version 3.1 and manual 
assignment of fragment ions was performed 
to confirm the search results.  
 
RESULTS 
 Lipid Selectivity of hSK1- 
Conflicting results have been reported on the 
lipid selectivity of SK. An earlier report 
showed that phosphatidylserine (PS) is the 
most effective activator of SK (26), whereas 
a recent report suggested that SK1 has the 
high affinity for phosphatidic acid (PA) 
(27). To resolve this controversy and 
determine the exact role of these lipids in 
membrane targeting of SK1, we first 
measured the in vitro membrane binding 
parameters of recombinant hSK1 using 
vesicles with various compositions by 
means of the SPR analysis. The SPR 
analysis of membrane- protein interactions 
offers an advantage over other methods in 
that membrane association (ka) and 
dissociation (kd) rate constants can be 
directly determined (21, 28- 30). We have 
recently shown that nonspecific electrostatic 
interactions driven by ionic residues mainly 
effect ka, whereas short- range specific 
interactions and hydrophobic interactions, 
which result from the membrane penetration 
of hydrophobic residues, largely influence kd 
(21, 20, 31). Fig. 1 shows representative 
sensorgrams for hSK1- vesicle binding from 
which ka, kd, and Kd were determined.  
 hSK1 did not bind to Zwitterionic 
POPC or POPE vesicles with protein 
concentrations up to 5μм,  ut sho ed higher 
affinity for vesicles containing anionic 
phospholipids. Because the inner plasma 
membrane of mammalian cells contains 
about 30 mol % of total anionic lipids, we 
first determined Kd values for mixed vesicles 
containing 30 mol % of various anionic 
lipids (i.e. POPC/POPX (70:30)). The 
comparison of Kd values (TABLE ONE) 
shows that hSK1 has definite selectivity for 
PS over other anionic phospholipids. 
Although hSK1 bound to PA slightly better 
than phosphatidylglycerol and 
phosphatidylinositol, it still showed 5- fold 
higher affinity for PS than for PA. When 
lower concentrations of anionic lipids were 
employed (e.g. POPC/POPX = 80:20 or 85: 
15), essentially the same PS selectivity was 
observed (data not shown).  
 
 
 
 
 
 
 
 
 
 
 
Also, the PS selectivity remained unchanged 
when pH of the binding solution was varied 
from 7.4 to 8.1 (i.e. [Kd for POPC/POPA 
(7:3)]/ [Kd for POPC/ POPS (7:3)] = 4.7 at 
pH 8.1), precluding the possibility that 
selectivity of hSK1 for PS over PA affinity 
reflects incomplete ionization of PA under 
our experimental conditions. Higher pH 
could not be used because of a loss of hSK1 
activity at pH > 8.3. Furthermore, the 
addition (up to 3 mol %) of SPH, PMA, 
diacylglycerol, or any phosphoinositides to 
POPC/ POPS (70:30) vesicles had little 
effect on the affinity of hSK1 (data not 
shown). Higher affinity (i.e. Kd) of hSK1 for 
PS derives mainly from smaller kd, which 
suggests that the PS head group specifically 
interacts with hSK1 and may also induce 
membrane penetration of hSK1 to slow the 
membrane dissociation.  
 It has been shown for many 
membrane- targeting domains and their host 
proteins that binding of their cognate lipid 
ligand leads to membrane penetration of the 
protein (31- 34). To see if PS specifically 
induces the membrane penetration of hSK1, 
we measured the penetration of hSK1 into 
various lipid monolayers at the air- water 
interface.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The phospholipid monolayer was spread at a 
constant area and the change in surface 
pressure (Δπ)  as monitored after injection 
of protein into the subphase. In general, Δπ 
is inversely proportional to πo of the lipid 
monolayer and an extrapolation of Δπ 
 
versus πo plot yields the critical surface 
pressure (πc), which specifies the upper limit 
of πo of a monolayer that a protein can 
penetrate into (24, 35). Because the surface 
pressure of cell membranes has been 
estimated to be in the range of 30- 35 dyne/ 
cm (36-  8), the πc value for a protein that 
penetrates cell membranes should be above 
30 dyne/ cm. As shown in Fig. 2A, hSK1 
showed weak penetration into the POPC, 
POPC/ POPG (7:3), POPC/ POPI (7:3), 
POPC/ POPA (7: ) monolayer  ith πc < 26 
dyne/ cm. However, hSK1 had stronger 
penetration activity toward the POPC/ POPS 
(7: ) monolayer  ith πc ≥  0 dyne/ cm. This 
suggests that PS specifically induces the 
membrane penetration of hSK1 and thus 
allows its favorable hydrophobic interaction 
with cell membranes. It should be noted that 
large unilamellar vesicles used in our SPR  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
measurements are known to have the surface 
pressure above 30 dyne/ cm (36- 38). This 
explains why hSK1 shows no affinity for 
switterionic POPC or POPE vesicles and 
weaker affinities for non- PS- containing 
anionic vesicles through nonspecific 
electrostatic interactions in the SPR 
measurements.  
 Our recent studies have shown that 
peripheral proteins with PS selectivity have 
a high tendency to be localized at the 
cytoplasmic face of the plasma membrane 
(22, 39, 40), either in response to specific 
signal or constitutively, because of high PS 
content of this membrane. Thus, the reported 
PMA- induced translocation of hSK1 to the 
plasma membrane (17) might derive, at least 
in part, from its preference for PS in the 
plasma membrane. To test this notion, we 
measured the binding of hSK1 to vesicles  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
has been successfully used to determine the 
origin of specific subcellular localization of 
various cellular proteins (31).  
As shown in TABLE TWO, hSK1 had 
striking selectivity for the plasma membrane 
mimetic over other cell membrane mimetics. 
In particular, it showed almost 400- fold 
higher affinity for the plasma membrane 
mimetic than for the nuclear membrane 
mimetic. It should be noted that this plasma 
membrane selectivity is much more 
dramatic than the PS selectivity determined 
above because the plasma membrane is not 
only rich in PS but also the most anionic 
membrane in all cell membranes. This 
exceptional selectivity of hSK1 for the 
plasma membrane mimetic strongly suggests 
the lipid head group selectivity be a main 
force governing its specific subcellular 
localization. This also implies that the 
agonist- induced plasma membrane 
translocation of this protein be regulated by 
modulating the lipid- protein interactions. 
whose lipid head group compositions mimic 
those of the cytoplasmic plasma membrane, 
the nuclear membrane, and early 
endosomes, respectively (22). This approach 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Structural Determinants of PS 
Selectivity and Cellular Membrane 
Targeting and Activation- The structural 
information on the stereospecific recognition 
of the PS head group by its effector protein 
is limited. IN the case of the C2 domain of 
PKCα that was crystallized with a PS 
molecule, the side chain of an Asn residue  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
directly interacts with the serine head 
group of PS, whereas the side chain of a Thr 
residue interacts with other polar moieties of 
PS (41). To identify potential PS binding 
residues in hSK1, we searched polar 
residues capable of interacting with the PS 
head group, i.e. Asn, Ser, or Thr, which are 
conserved among SKs (Fig. 3). The search 
identified at least eight highly conserved 
residues, including, Thr
54
, Ser
79
, Asn
89
, 
Ser
112
, Asn
114
, Ser
119
, Ser
165
, and Ser
168
. To 
see if any of these residues are involved in 
PS head group recognition, we mutated 
them to Ala individually and measured the 
effects on PS selectivity. For the sake of 
simplicity, we determined the PS selectivity 
of mutants by comparing their affinity for 
POPC/ POPS (7:3) and POPC/ POPG (7:3) 
vesicles. Interestingly, T54A and N89A 
showed dramatically reduced PS selectivity 
(TABLE ONE), whereas S168A (TABLE 
ONE) and other mutants (data not shown) 
either behaved like wild type or were not 
functionally expressed, implying that Thr
54 
and/ or Asn
89
 might be specifically involved 
in PS interaction. Interestingly, Asn
89
 is 
located within the putative ATO- binding 
region (between residue 82 and residue 103) 
(Fig. 3) (42), which should be located near 
the membrane- binding surface for hSK1 to 
be able to phosphorylate the membrane- 
imbedded substrate, SPH. Reduced PS 
selectivity of T54A and N89A was not 
because of deleterious structural changes  
caused by mutations because these mutants 
showed only slightly reduced affinity for 
POPC/ POPG (7:3) vesicles (TABLE ONE). 
Consistent with their reduced PS selectivity, 
T54A and N89A also had much lower (i.e. 
22- to 24- fold) selectivity for the plasma 
membrane mimetic over the nuclear  
membrane mimetic than the wild type (373- 
fold; TABLE TWO). It should be noted that 
despite their lack of PS selectivity T54A and 
N89A still prefer the plasma membrane 
mimetic to other cell membrane mimetics 
because the highly anionic nature of the 
plasma membrane mimetic allows favorable 
nonspecific electrostatic interactions with 
these proteins.  
To determine whether these PS- 
binding residues are also important for the 
enzymatic activity of hSK1, we performed 
in vitro activity assays for wild type, T54A, 
N89A, and S168A in the absence and 
presence of lipid vesicles of various 
compositions. When the activity was 
measured in the absence of lipid vesicles, 
wild type and all mutants had comparable 
specific activities (Fig. 4), indicating the 
mutations did not disrupt the structural 
integrity of the active site of the enzyme. 
When the activity was measured using SPH 
incorporated into zwitterionic PC vesicles, 
no increase in activity was observed for any 
protein (Fig. 4). When anionic POPC/ POPA 
(7:3) vesicles were used in the activity 
assay, wild type and all mutants uniformly 
showed about a 2.5- fold enhanced activity 
(Fig. 4). In the presence of POPC/ POPS 
(7:3) vesicles, however, wild type and 
S168A showed significantly higher activity 
than T54A and N89A (Fig. 4). Interestingly, 
T54A and N89A showed similar activities in 
the presence of POPC/ POPA (7:3) and 
POPC/POPS (7:3) vesicles, indicating that 
the PA activation is largely because of 
nonspecific electrostatic binding to anionic 
membranes, whereas the PS activation is a 
specific process.  
These data thus indicate that specific 
PS binding of hSK1 mediated by Thr
54
 and 
Asn
89
 is important not only for membrane 
binding of hSK1 but also for the enzymatic 
action of hSK1 on membrane- incorporated 
SPH. 
  
 To see if Thr
54
 and Asn
89
 also play a 
key role in the subcellular localization of 
hSK1, we measured the cellular membrane 
translocation of hSK1 and mutants in 
HEK293 cells. The Western blotting 
analysis using a hSK1- specific antibody 
(17) indicated that all proteins were 
expressed in comparable levels (data not 
shown). The C- terminal EGFP- tagged 
hSK1 transiently transfected into HEK293 
cells was recruited to the plasma membrane 
within 10 min in response to PMA 
stimulation (Fig. 5A). In stark contrast, 
EGFP- T54A (Fig. 5B) and EGFP- N89A 
(Fig. 5D) showed no detectable translocation 
under the same conditions. Unlike these 
mutants, EGFP- S168A with wild type- like 
membrane binding properties readily 
translocated to the plasma membrane upon 
PMA treatment (Fig. 5C).  
 We then measured the cellular 
activity of these proteins by labeling the 
aforementioned transfected HEK293 cells 
with ᴅ- [erythro- 3H]SPH and monitoring 
the release of the radioactive S1P into the 
media. As shown in Fig. 6, PMA induced a 
4- fold increase in S1P release over the 
control for wild type and S168A, whereas 
little to no increases in S1P release over the 
controls were detected for T54A and N89A 
with and without PMA. Collectively, these  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
results indicate that Thr
54
 and Asn
89
, located 
in the putative membrane- binding surface 
of hSK1, play an essential role in its PS head 
group recognition, subcellular localization, 
and cellular activity. This also supports the 
notion that the subcellular localization of 
hSK1 is governed in large part by the lipid- 
protein interactions. 
Effect of Ser
225
 Phosphorylation on 
the Membrane Targeting of hSK1- It has 
been reported that Ser
225
 of SK1 is 
phosphorylated by extracellular signal- 
regulated kinase 1/2 in response to PMA or 
tumor necrosis factor-  α stimulation in 
HEK293 cells, which leads to PM targeting 
and activation of SK1 (18).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To investigate how Ser
225 
phosphorylation activates hSK1, we 
prepared phosphorylation and 
dephosphorylation- mimicking mutants, 
S225E and S225A, and measured their 
binding to cell membrane mimetics. As 
summarized in TABLE TWO, the 
membrane affinity of S225E was 
comparable with that of wild type, implying 
that a large population of hSK1 molecules 
expressed in insect cells are phosphorylated 
at Ser
225
. To test this notion, we determined 
the phosphorylation of Ser
225 
in insect cell- 
expressed recombinant hSK1 by mass 
analysis. Tandem mass spectrometry data of 
tryptic peptide fragments containing Ser
225 
(Fig. 7) consistently showed that Ser
225
 was 
phosphorylated in hSK1 expressed in insect 
cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Although quantification is 
impractical with the current mass 
spectrometry analysis,  
the relative height of phosphorylated and 
non- phosphorylated.  
Most important, S225E had about 10 
times higher affinity (i.e. lower Kd) for the 
plasma membrane mimetic than S225A, 
establishing that Ser
225
 phosphorylation 
greatly enhances the affinity of hSK1 for the 
plasma membrane. Interestingly, the S225A 
mutation lowered the membrane affinity 
primarily by increasing kd, which is 
reminiscent of the effect of the T54A and 
N89A mutations. This implies that Ser
225
 
phosphorylation may be somehow linked to 
the PS- mediated membrane interactions of 
Asn
89
 and Thr
54
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This notion is supported by the finding that 
S225A, like T54A and N89A, had 
significantly reduced selectivity for the 
plasma membrane mimetic over the nuclear 
membrane mimetic than did S225E and wild 
type (TABLE TWO). 
Furthermore, in a monolayer 
penetration assay using the POPC/ POPS 
(7:3) monolayer, S225A, T54A, and N89A 
all had significantly lower πc values than 
S225E and wild type (Fig. 2B). In particular, 
the penetration of S225A into the POPC/ 
POPS (7:3) monolayer was comparable with 
the penetration of wild type hSK1 into non- 
PS containing monolayers (Fig. 2A). These 
results suggest that Ser
225 
phosphorylation 
may regulate the membrane targeting of 
hSK1 by modulating the specific interaction 
of Asn
89 
and Thr
54
 with the PS- containing 
membrane.  
We also measured the cellular 
membrane targeting of C- terminal EGFP- 
tagged hSK1, S225A, and S225E transiently 
transfected into HEK293 cells. When 
transfected cells were stimulated with PMA, 
S225E translocated to the plasma membrane 
as well as wild type (Fig. 5E), whereas 
S225A translocated significantly more 
slowly than wild type (Fig. 5F), in 
accordance with its lower in vitro membrane 
affinity. Collectively, these results indicate 
that Ser
225
 phosphorylation regulates the 
membrane targeting of hSK1 both in vitro 
and in the cell, presumably by modulating 
the interactions of Asn
89
 and Thr
54
 with the 
membrane.  
 
DISCUSSION  
 
 This study systematically 
investigates the mechanism by which 
subcellular localization and activation of 
SK1 is regulated. Because the main 
physiologic substrate of SK1 is the  
membrane lipid SPH and SK1 is normally a 
cytosolic protein, the activation of SK1 
should involve its membrane recruitment 
either through protein- lipid and/ or protein- 
protein interactions. Although some proteins 
have been reported to interact with SK1 (19, 
20), the physiological relevance of protein- 
mediated subcellular localization of SK1 has 
not been established. The present study  
provides new evidence supporting the notion 
that the lipid- protein interactions play a 
major role in regulation of membrane 
translocation and activation of SK1: i.e. 
specific plasma membrane targeting SK1 
derives from its selectivity for the PS head 
group and the phosphorylation of Ser
225
 
activates SK1 by enhancing its plasma 
membrane affinity.  
 Although direct structural 
information is not available for any SK at 
present, the sequence comparison of SKs 
from different species allowed us to identify 
the residues essential for the PS specificity 
of hSK1. Our in vitro vesicle binding 
measurements of wild type and mutants 
indicate that hSK1 specifically interacts with 
PS via the side chains of Thr
54
 and Asn
89
. 
These data, in conjunction with the fact that 
the cellular concentration of OS is much 
higher than PA, strongly dispute the notion 
that SK1 might act as a specific PA effector 
in the cell (27). The PS specificity of hSK1 
would allow the protein to translocate 
selectivity to the cytoplasmic leaflet of the 
plasma membrane that is rich in PS. The 
notion is supported by exceptional 
selectivity of hSK1 for the plasma 
membrane mimetic over other cell 
membrane mimetics, which is dramatically 
reduced by the T54A or N89A mutations. 
Thus, along with the C2 domains of protein 
kinase Cα and phospholipase Cδ1 (22, 39), 
hSK1 belongs to an expanding group of 
cellular signaling proteins that are targeted 
to the plasma membrane from the cytosol 
because of their selectivity for the PS head 
group.  
 
  
 
 
 
 
 
 
 
 
 
  
 
 
In the case of PKCα, PS has been reported 
to specifically induce the conformational 
change and membrane penetration of the 
protein (43, 44). This PS- mediated process 
not only enhances the membrane affinity of 
PKCα but also activates the protein by 
opening the active site of the enzyme. It is 
difficult to directly compare the activation 
mechanisms of PKCα and SK1 because 
PKCα activation also involves 
diacylglycerol. A main similarity is, 
however, that PS enhances the membrane 
penetration of both proteins, thereby 
increasing their residence time (i.e. smaller 
kd) and affinity (i.e. smaller Kd) for densely 
packed lipid bilayers including cell 
membranes. Because little is known about 
the enzyme activation mechanism of SK1, it 
is unclear whether the PS- induced 
membrane penetration of SK1 would simply 
enhance the membrane affinity or also cause 
the enzyme activation at the membrane 
surface. More studies are needed to address 
this important issue.  
The mechanism by which 
phosphorylation regulates the membrane 
targeting and activation of SK has not been 
elucidated. It has been reported that 
phosphorylation of Ser
225
 activates SK1 
presumably by promoting its plasma 
membrane targeting (18). Our results  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
indicate that phosphorylation of 
Ser
225
 not only enhances the overall 
membrane binding affinity of hSK1 but also 
increases its selectivity for the plasma 
membrane. This raises an interesting 
possibility that phosphorylation of Ser
225
 
modulates the interaction of the two PS- 
binding residues, Asn
89
 and Thr
54
, with the 
membrane. This notion is supported by our 
monolayer penetration measurements 
showing that Ser
225
 phosphorylation 
enhances the penetration of hSK1 into the 
PS- containing monolayer. The relative 
location of Ser
225
 and the PS- binding 
residues in hSK1 are not known at present. 
If they are located in proximity, Ser
225
 
phosphorylation would regulate the 
membrane interaction of these residues 
through short- range electrostatic 
interactions. If, on the other hand, Ser
225
is 
remote from Asn
89
 and Thr
54
, Ser
225
 
phosphorylation would regulate the 
membrane binding through a long- range 
conformational change, as seen with other 
membrane- binding proteins, such as 
cytosolic phospholipase A2α (45). 
 On the basis of these results and 
other available data, we propose a 
mechanism by which the membrane 
targeting and activation of SK1 is regulated 
in the cell (Fig. 8). When Ser
225
 is not 
phosphorylated, SK1 cannot fully exert its 
 
PS- specific binding and therefore only 
weakly interacts with the anionic plasma 
membrane through nonspecific electrostatic 
interactions Phosphorylation of Ser
225
 allows 
Thr
54
 and Asn
89
 to specifically interact with 
PS in the plasma membrane, which induces 
partial membrane penetration of SK1 and 
greatly enhances the membrane affinity of 
SK1. Slower membrane dissociation and 
elongated membrane residence of SK1 
caused by specific PS binding will allow 
SK1 to laterally diffuse in the plane of 
membrane, finding its substrate SPH, to 
catalyze the phosphorylation in a processive 
manner. Our hypothetical model is based on 
the premise that the activation of SK1 is 
regulated mainly at the stage of its 
membrane binding: i.e. cell stimuli activate 
SK1 mainly by enhancing its membrane 
affinity. This notion is consistent with the 
good quantitative correlation between the in 
vitro affinities of hSK1 and mutants for the 
plasma membrane mimetic and their cellular 
properties. Such a correlation would not be 
expected if, for instance, Ser
225
 
phosphorylation mediated protein- protein 
interactions. It should be noted that this 
model is still largely hypothetical and 
further structural and functional studies are 
necessary to test the model. For instance, 
there are no possibilities that some cellular 
agonists of SK1 and other types of SK1 
phosphorylation may mediate protein- 
protein interactions. Nonetheless, this study 
provides new insights into the mechanism 
by which the membrane recruitment of this 
important protein is regulated and also lays 
the groundwork for more systematic 
mechanistic and functional studies.  
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